+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Thrombosis Drug Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

  • ID: 4757177
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

FEATURED COMPANIES

  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • GlaxoSmithKline Plc.
  • Johnson & Johnson
  • MORE
The report on the global thrombosis drug market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global thrombosis drug market to grow with a CAGR of 9.1% over the forecast period from 2018-2024. The study on thrombosis drug market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on thrombosis drug market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global thrombosis drug market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global thrombosis drug market over the period of 2016 to 2024. Further, the author's growth matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers
  • Growth in the number of cardiovascular and trauma cases
  • Increase in the number of geriatric population
2. Restraints
  • Side-effects caused owing to thrombosis drugs
  • Lack of consciousness regarding venous thromboembolism conditions
3. Opportunities
  • Growing occurrences of deep vein thrombosis
Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global thrombosis drug market is segmented on the basis of drug class, disease type, and distribution channel.

The Global Thrombosis Drug Market by Drug Class
  • P2Y12 Platelet Inhibitor
  • Factor Xa Inhibitor
  • Heparin
The Global Thrombosis Drug Market by Disease Type
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Atrial Fibrillation
The Global Thrombosis Drug Market by Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Company Profiles

The companies covered in the report include:
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Johnson & Johnson
  • Sanofi
  • Aspen Pharmacare Holdings Limited
  • Bayer AG
  • Bristol-Myers Squibb
  • Pfizer, Inc
  • Baxter International, Inc.
  • GlaxoSmithKline Plc.
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the thrombosis drug market.
2. Complete coverage of all the segments in the thrombosis drug market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global thrombosis drug market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
4. The growth matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • GlaxoSmithKline Plc.
  • Johnson & Johnson
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Thrombosis Drug Market Highlights
2.2. Thrombosis Drug Market Projection
2.3. Thrombosis Drug Market Regional Highlights

3. Global Thrombosis Drug Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Class
3.4.2. Growth Matrix Analysis by Disease Type
3.4.3. Growth Matrix Analysis by Distribution Channel
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Thrombosis Drug Market

4. Thrombosis Drug Market Macro Indicator Analysis

5. Global Thrombosis Drug Market by Drug Class
5.1. P2Y12 Platelet Inhibitor
5.2. Factor Xa Inhibitor
5.3. Heparin

6. Global Thrombosis Drug Market by Disease Type
6.1. Deep Vein Thrombosis
6.2. Pulmonary Embolism
6.3. Atrial Fibrillation

7. Global Thrombosis Drug Market by Distribution Channel
7.1. Online Pharmacies
7.2. Hospital Pharmacies
7.3. Retail Pharmacies

8. Global Thrombosis Drug Market by Region 2018-2024
8.1. North America
8.1.1. North America Thrombosis Drug Market by Drug Class
8.1.2. North America Thrombosis Drug Market by Disease Type
8.1.3. North America Thrombosis Drug Market by Distribution Channel
8.1.4. North America Thrombosis Drug Market by Country
8.2. Europe
8.2.1. Europe Thrombosis Drug Market by Drug Class
8.2.2. Europe Thrombosis Drug Market by Disease Type
8.2.3. Europe Thrombosis Drug Market by Distribution Channel
8.2.4. Europe Thrombosis Drug Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Thrombosis Drug Market by Drug Class
8.3.2. Asia-Pacific Thrombosis Drug Market by Disease Type
8.3.3. Asia-Pacific Thrombosis Drug Market by Distribution Channel
8.3.4. Asia-Pacific Thrombosis Drug Market by Country
8.4. RoW
8.4.1. RoW Thrombosis Drug Market by Drug Class
8.4.2. RoW Thrombosis Drug Market by Disease Type
8.4.3. RoW Thrombosis Drug Market by Distribution Channel
8.4.4. RoW Thrombosis Drug Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Thrombosis Drug Market
9.2. Companies Profiles
9.2.1. AstraZeneca PLC
9.2.2. Boehringer Ingelheim GmbH
9.2.3. Johnson & Johnson
9.2.4. Sanofi
9.2.5. Aspen Pharmacare Holdings Limited
9.2.6. Bayer AG
9.2.7. Bristol-Myers Squibb
9.2.8. Pfizer, Inc
9.2.9. Baxter International, Inc.
9.2.10. GlaxoSmithKline Plc.

10. Appendix
10.1.Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Johnson & Johnson
  • Sanofi
  • Aspen Pharmacare Holdings Limited
  • Bayer AG
  • Bristol-Myers Squibb
  • Pfizer, Inc
  • Baxter International, Inc.
  • GlaxoSmithKline Plc.
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4757177
Adroll
adroll